Evofem Biosciences Reports First Quarter 2021 Financial Results and Provides Corporate Update

Go back to Evofem Biosciences Reports First Quarter 2021 Financial Results and Provides Corporate Update

Evofem Biosciences (EVFM) Misses Q1 EPS by 7c

May 6, 2021 6:11 PM EDT

Evofem Biosciences (NASDAQ: EVFM) reported Q1 EPS of ($0.56), $0.07 worse than the analyst estimate of ($0.49). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.63 million.

For earnings history and earnings-related data on Evofem Biosciences (EVFM) click here.

... More